Genpact Limited
G
$43.54
$1.303.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.25B | 1.21B | 1.18B | 1.13B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.21B | 1.25B | 1.21B | 1.18B | 1.13B |
| Cost of Revenue | 785.93M | 802.97M | 779.51M | 759.83M | 734.76M |
| Gross Profit | 428.99M | 445.77M | 431.44M | 416.38M | 396.48M |
| SG&A Expenses | 241.08M | 252.22M | 243.32M | 239.64M | 235.03M |
| Depreciation & Amortization | 4.32M | 6.50M | 6.50M | 6.56M | 6.93M |
| Other Operating Expenses | -112.00K | -55.00K | -22.00K | -73.00K | -3.97M |
| Total Operating Expenses | 1.03B | 1.06B | 1.03B | 1.01B | 972.75M |
| Operating Income | 183.70M | 187.11M | 181.65M | 170.25M | 158.49M |
| Income Before Tax | 175.22M | 182.55M | 175.49M | 162.42M | 156.37M |
| Income Tax Expenses | 44.37M | 40.63M | 42.67M | 40.43M | 39.42M |
| Earnings from Continuing Operations | 130.85M | 141.92M | 132.82M | 121.99M | 116.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 130.85M | 141.92M | 132.82M | 121.99M | 116.95M |
| EBIT | 183.70M | 187.11M | 181.65M | 170.25M | 158.49M |
| EBITDA | 204.41M | 210.99M | 204.94M | 193.56M | 182.16M |
| EPS Basic | 0.75 | 0.81 | 0.75 | 0.68 | 0.65 |
| Normalized Basic EPS | 0.62 | 0.65 | 0.62 | 0.57 | 0.54 |
| EPS Diluted | 0.73 | 0.79 | 0.74 | 0.67 | 0.64 |
| Normalized Diluted EPS | 0.61 | 0.64 | 0.61 | 0.56 | 0.53 |
| Average Basic Shares Outstanding | 175.53M | 175.88M | 177.60M | 179.65M | 180.42M |
| Average Diluted Shares Outstanding | 178.44M | 179.18M | 179.71M | 180.91M | 181.94M |
| Dividend Per Share | 0.17 | 0.15 | 0.15 | 0.15 | 0.15 |
| Payout Ratio | 22.76% | 18.81% | 20.28% | 22.41% | 23.51% |